Nice

News

Vydura is first NICE-backed oral GPCR for acute migraine

Pfizer's Vydura has become the first drug in the oral GPCR receptor antagonist class to be recommended for routine NHS use as a treatment for acute migraine.

News

NICE changes its mind on Lilly's Mounjaro for diabetes

Around 180,000 people with type 2 diabetes in the UK could be in line for treatment with Eli Lilly's Mounjaro after the drug was recommended for NHS use by cost-effectiven

Patients

Patient involvement at NICE: In whose interest is it anyway?

The National Institute for Health and Care Excellence (NICE) released a new

News

'Virtual wards' for respiratory infections backed by NICE

NICE has said that patients with acute respiratory infections can be cared for at home rather than in a hospital, with the help of digital platforms that transmit informat

News

Keytruda backed for 'basket' of new cancers via NHS

The UK's cost-effectiveness agency NICE has recommended MSD's PD-1 inhibitor Keytruda for a series of cancers based on genetic abnormalities known as microsatellite instab

News